Post by Merz Therapeutics

Our partnership with Grünenthal is expanding into Brazil. From July 1, 2026, Grünenthal Brasil will take on commercialization responsibilities for our therapeutic option in movement disorders, building on our existing presence in the country. By extending our collaboration across key markets in Latin America, such as Brazil, Colombia, Ecuador and Mexico, we are strengthening how we work together to support patient care. Learn more here: https://lnkd.in/eChWC2K5 #MerzTherapeutics #Partnerships